Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M87,027Revenue $M126,761Net Margin (%)3.6Z-Score4.4
Enterprise Value $M96,252EPS $3.7Operating Margin %6.3F-Score8
P/E(ttm))19.6Cash Flow Per Share $4.1Pre-tax Margin (%)5.9Higher ROA y-yY
Price/Book2.310-y EBITDA Growth Rate %12.7Quick Ratio0.7Cash flow > EarningsY
Price/Sales0.75-y EBITDA Growth Rate %10.6Current Ratio1.6Lower Leverage y-yN
Price/Cash Flow11.4y-y EBITDA Growth Rate %19.9ROA % (ttm)6.4Higher Current Ratio y-yY
Dividend Yield %1.3Insider Buy (3m)0ROE % (ttm)12.1Less Shares Outstanding y-yY
Payout Ratio %24.0Shares Outstanding M1,228ROI % (ttm)8.1Gross Margin Increase y-yY

Gurus Latest Trades with CVS

Number of guru portfolios checked: 54.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
CVSVanguard Health Care Fund 2013-12-31 Add0.23%$56.64 - $71.58
($64.24)
$ 73.4414%Add 31.57%4,388,100
CVSPRIMECAP Management 2013-12-31 Add0.01%$56.64 - $71.58
($64.24)
$ 73.4414%Add 39.63%518,630
CVSWallace Weitz 2013-12-31 Reduce-0.41%$56.64 - $71.58
($64.24)
$ 73.4414%Reduce -95.05%10,000
CVSRay Dalio 2013-12-31 Sold Out -0.08%$56.64 - $71.58
($64.24)
$ 73.4414%Sold Out0
CVSJoel Greenblatt 2013-12-31 Reduce-0.07%$56.64 - $71.58
($64.24)
$ 73.4414%Reduce -90.39%4,288
CVSJames Barrow 2013-12-31 Reduce-0.02%$56.64 - $71.58
($64.24)
$ 73.4414%Reduce -36.87%361,095
CVSRay Dalio 2013-09-30 Buy 0.08%$57.28 - $62.17
($59.67)
$ 73.4423%New holding, 175050 sh.175,050
CVSJoel Greenblatt 2013-09-30 Add0.03%$57.28 - $62.17
($59.67)
$ 73.4423%Add 58.84%44,606
CVSPRIMECAP Management 2013-09-30 Add0.03%$57.28 - $62.17
($59.67)
$ 73.4423%Add 1668.71%371,430
CVSVanguard Health Care Fund 2013-06-30 Add0.34%$54.13 - $60.35
($57.94)
$ 73.4427%Add 96.21%3,335,100
CVSScott Black 2013-06-30 Add0.13%$54.13 - $60.35
($57.94)
$ 73.4427%Add 11.41%193,337
CVSWallace Weitz 2013-06-30 Reduce-0.77%$54.13 - $60.35
($57.94)
$ 73.4427%Reduce -63.92%201,200
CVSRay Dalio 2013-06-30 Sold Out -0.17%$54.13 - $60.35
($57.94)
$ 73.4427%Sold Out0
CVSJoel Greenblatt 2013-06-30 Reduce-0.09%$54.13 - $60.35
($57.94)
$ 73.4427%Reduce -53.31%28,083
CVSVanguard Health Care Fund 2013-03-31 Add0.3%$48.35 - $55.3
($51.98)
$ 73.4441%Add 466.6%1,699,800
CVSWallace Weitz 2013-03-31 Reduce-0.58%$48.35 - $55.3
($51.98)
$ 73.4441%Reduce -32.31%557,700
CVSJohn Hussman 2013-03-31 Sold Out -0.32%$48.35 - $55.3
($51.98)
$ 73.4441%Sold Out0
CVSRay Dalio 2013-03-31 Reduce-0.13%$48.35 - $55.3
($51.98)
$ 73.4441%Reduce -44.46%340,450
CVSJoel Greenblatt 2013-03-31 Reduce-0.07%$48.35 - $55.3
($51.98)
$ 73.4441%Reduce -30.68%60,144
CVSJames Barrow 2013-03-31 Reduce-0.02%$48.35 - $55.3
($51.98)
$ 73.4441%Reduce -27%686,895
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

CVS is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
CVS PRIMECAP Management 2013-12-31518,6300.040.05+39.63%
CVS Vanguard Health Care Fund 2013-12-314,388,1000.360.97+31.57%
CVS Mario Gabelli 2013-12-311,600,3370.130.61-0.2%
CVS Ruane Cunniff 2013-12-3125,45400.01-1.83%
CVS Scott Black 2013-12-31180,6270.011.4-3.4%
CVS James Barrow 2013-12-31361,0950.030.04-36.87%
CVS Joel Greenblatt 2013-12-314,28800.01-90.39%
CVS Wallace Weitz 2013-12-3110,00000.02-95.05%
CVS Ray Dalio 2013-12-31000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


CVS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Boratto Eva CSVP, Cont & Chief Acct Officer 2014-04-02Sell17,108$74.51-1.44view
Sussman AndrewSVP & President, MinuteClinic 2014-04-02Sell19,210$74.02-0.78view
Brennan Troyen AEVP, Chief Medical Officer 2014-03-31Sell18,867$74.33-1.2view
Denton David MEVP, CFO 2014-01-03Sell14,113$70.54.17view
Lofberg Per GHEVP and President, Caremark 2014-01-03Sell790,888$70.544.11view
Joyner J. DavidEVP, Sales & Account Services 2014-01-03Sell220,385$70.494.18view
Roberts Jonathan CEVP & President, Caremark 2014-01-02Sell162,192$70.614.01view
MERLO LARRY JPresident and CEO 2014-01-02Sell228,875$70.763.79view
Bisaccia LisaSVP, Chief HR Officer 2013-12-10Sell12,057$688view
Boratto Eva CSVP, Cont & Chief Acct Officer 2013-11-22Sell6,654$66.510.44view

Press Releases about CVS :

    Quarterly/Annual Reports about CVS:

    News about CVS:

    Articles On GuruFocus.com
    GAMCO CIO Howard Ward on Reliable Consumer Stock Ideas Apr 09 2014 
    Different Opinions on Bio-Rad Laboratories Apr 03 2014 
    Walgreen Co. (WAG) Dividend Stock Analysis Mar 28 2014 
    Will Altria Be Able to Offset Declines in Tobacco Sales? Mar 26 2014 
    Davis Selected Advisers Chris Davis' Top Five Holdings at Year-End Feb 13 2014 
    Jeff Auxier Comments on CVS Feb 13 2014 
    Steven Romick’s Top Five Q4 Holdings Jan 14 2014 
    Weekly CFO Sells Highlight: CVS Caremark Corp, Facebook Inc, Hertz Global Holdings Inc. Jan 13 2014 
    Weekly CEO Sells Highlight: CVS Caremark Corp, Actuant Corp, Aetna Inc, and Quality Distribution Inc Jan 05 2014 
    Top Guru-Held Consumer Defensive Stocks Dec 16 2013 

    More From Our Partners
    Rite Aid Upped to Strong Buy - Analyst Blog Apr 15 2014 - ZACKS

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Hide